tradingkey.logo

tradingkey.logo
怜玢


IDEXX Laboratories Inc

IDXX
りォッチリストに远加
520.050USD
-0.160-0.03%
取匕時間 09/09, 09:58ET
41.02B時䟡総額
38.00盎近12ヶ月PER

詳现情報 IDEXX Laboratories Inc 䌁業名

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

IDEXX Laboratories Inc プロフィヌル


䌁業コヌドIDXX
䌚瀟名IDEXX Laboratories Inc
䞊堎日Jun 21, 1991
最高経営責任者「CEO」Emerson (Andrew)
埓業員数11000
蚌刞皮類Ordinary Share
決算期末Jun 21
本瀟所圚地One Idexx Drive
郜垂WESTBROOK
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号04092-2041
電話番号12075560300
りェブサむトhttps://www.idexx.com/
䌁業コヌドIDXX
䞊堎日Jun 21, 1991
最高経営責任者「CEO」Emerson (Andrew)

IDEXX Laboratories Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Michael G. (Mike) Erickson, Ph.D.
Mr. Michael G. (Mike) Erickson, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
15.00K
+25.25%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Lead Independent Director
Lead Independent Director
8.57K
+3.96%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.43K
+3.05%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager - CAG Diagnostics Business Unit
Executive Vice President and General Manager - CAG Diagnostics Business Unit
8.25K
-3.84%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.89K
+2.86%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
4.34K
+4.13%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.35K
+7.66%
Mr. Michael Schreck
Mr. Michael Schreck
Executive Vice President and General Manager - Veterinary Software, Diagnostic Imaging and Telemedicine, Corporate Accounts and Customer Experience
Executive Vice President and General Manager - Veterinary Software, Diagnostic Imaging and Telemedicine, Corporate Accounts and Customer Experience
3.00K
+36.06%
Mr. Bruce L. Claflin
Mr. Bruce L. Claflin
Independent Director
Independent Director
1.72K
--
Ms. Irene Chang Britt
Ms. Irene Chang Britt
Independent Director
Independent Director
208.00
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Michael G. (Mike) Erickson, Ph.D.
Mr. Michael G. (Mike) Erickson, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
15.00K
+25.25%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Lead Independent Director
Lead Independent Director
8.57K
+3.96%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.43K
+3.05%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager - CAG Diagnostics Business Unit
Executive Vice President and General Manager - CAG Diagnostics Business Unit
8.25K
-3.84%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.89K
+2.86%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
4.34K
+4.13%

よくある質問

IDEXX Laboratories Incの䞊䜍5名の株䞻は誰ですか


IDEXX Laboratories Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Michael G. (Mike) Erickson, Ph.D.

IDEXX Laboratories IncIDXXの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、IDEXX Laboratories Incの株匏を保有しおいる機関は2458瀟あり、保有株匏の総垂堎䟡倀は玄76.16Mで、党䜓の96.54%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-2089033.00増加しおいたす。

IDEXX Laboratories Incの最倧の収益源は䜕ですか


2026Q1においお、CAG Diagnostics recurring revenue郚門がIDEXX Laboratories Incにずっお最倧の収益を生み出しおおり、その金額は974.71Mで、党収益の80.12%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。